Incheon, South Korea

Yi Xian Li

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Nextbiomedical Co., Ltd., Nextbiomedical Co., Ltd.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi Xian Li. Retrieved from https://idiyas.com/inventor/yi-xian-li-9j6ny959

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yi Xian Li: Inventor of Biodegradable Embolization Hydrogels

Introduction

Yi Xian Li is an inventor based in Incheon, South Korea. His patent work focuses on embolization hydrogels and biodegradable microparticles designed for use in medical treatments. He is associated with 2 patents.

Latest Patents

- Embolization hydrogel having controllable degradation time, and preparation method therefor. This invention concerns spherical, amorphous embolization hydrogel particles designed to degrade in blood vessels over a precisely controllable period. It also describes a method for preparing the hydrogel.

- Hydration gel particle for chemoembolization comprising biodegradable polymer. This invention describes biodegradable microparticles intended to carry anticancer drugs for embolization, along with a method for manufacturing them. The particles are designed to adsorb anticancer agents effectively and quickly, while allowing their breakdown time in the body to be controlled. These properties may support treatment effectiveness and help minimize side effects during chemoembolization.

Career Highlights

Li is associated with Nextbiomedical Co., Ltd. His listed patent work reflects an emphasis on developing materials for targeted cancer treatment and controlling how those materials behave in the body.

Collaborations

His listed collaborators include Choong Ryeol Choi and Don Haeng Lee. Their names appear in connection with his work on embolization and drug-delivery technologies.

Conclusion

Yi Xian Li’s patent portfolio highlights biodegradable hydrogel and microparticle technologies designed to support controlled embolization and chemoembolization treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…